In part 5, the conclusion of this Exclusive Interview, Dace Trence talks with Diabetes in Control during the AACE 2018 convention in Boston about diabetes and cardiovascular combo therapy, and how new medications and precision medicine are changing diabetes care.Read More »
Elevated eGR fund to possibly lead to renal damage.Read More »
Even as 2nd-line drugs, sulfonylureas shown to be cardiotoxic with high rate of low blood glucoseRead More »
Patients who have normoglycemia still at risk for glucose spikes and diabetes.Read More »
Study investigates preservation or improvement of B-cell function using metformin with or without short-term insulin.Read More »
Guest Post by David Kliff, Editor, Diabetic Investor
This weekend, the most dedicated people in diabetes will gather in Baltimore for the AADE conference. Year after year, these amazing people gather to see all the latest toys in the toy chest, learn about all the new drugs, and share insights into how they are impacting the lives of the patients they work with.
Would you be more open to prescribing a GLP-1 Inhibitor if there was an oral product rather than an injectable? Follow the link to share your opinion and see what your colleagues think.Read More »
According to a recent study, frequently consuming meat, poultry, or fish cooked at high temperatures increases the risk for hypertension by how much?
Follow the link for the answer.Read More »
Man, 67 years of age, had been on GLP-1, SGLT-2, and metformin for over 4 years without difficulty or reported untoward side effects. He started taking the SGLT-2 before most health care professionals knew about the risk of DKA in people who have type 2 diabetes when taking SGLT-2s.Read More »
Stanley Schwartz, MD, FACP, FACE is an Affiliate of the Main Line Health System, and an Emeritus Associate Professor of Medicine at the University of Pennsylvania, currently in a private practice in Ardmore, Pa. Dr. Schwartz received his MD in 1973 from the University of Chicago in Chicago, Illinois. He then completed his residency at the University of Pennsylvania, followed by a fellowship in endocrinology and metabolism at the University of Chicago.Read More »